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Mutation in CUL4B, Which Encodes a Member of Cullin-RING
Ubiquitin Ligase Complex, Causes X-Linked Mental Retardation
Yongxin Zou,* Qiji Liu,* Bingxi Chen, Xiyu Zhang, Chenhong Guo, Haibin Zhou, Jiangxia Li,
Guimin Gao, Yishou Guo, Chuanzhu Yan, Jianjun Wei,† Changshun Shao, and Yaoqin Gong
We reevaluated a previously reported family with an X-linked mental retardation syndrome and attempted to identify
the underlying genetic defect. Screening of candidate genes in a 10-Mb region on Xq25 implicated CUL4B as the causative
gene. CUL4B encodes a scaffold protein that organizes a cullin-RING (really interesting new gene) ubiquitin ligase (E3)
complex in ubiquitylation. A base substitution, c.1564CrT, converted a codon for arginine into a premature termination
codon, p.R388X, and rendered the truncated peptide completely devoid of the C-terminal catalytic domain. The nonsense
mutation also results in nonsense-mediated mRNA decay in patients. In peripheral leukocytes of obligate carriers, a strong
selection against cells expressing the mutant allele results in an extremely skewed X-chromosome inactivation pattern.
Our ﬁndings point to the functional signiﬁcance of CUL4B in cognition and in other aspects of human development.
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Mental retardation (MR) affects ∼2% of the human pop-
ulation and represents a major health care challenge.1 Al-
though its etiology is very heterogeneous, the largest sin-
gle category, accounting for ∼10% of all types of MR, is
caused by mutations at various loci on the X chromosome
and is called “X-linked mental retardation” (XLMR).2,3
XLMR can be divided into syndromic and nonsyndromic
forms on the basis of the presence or absence of other
symptoms and features. Since the early 1990s, genetic
studies of families with XLMR have led to the identiﬁ-
cation of at least 61 X-linked loci that are responsible for
MR.3 The identiﬁcation of such genetic defects is invalu-
able in discovering genes that govern brain function and
cognition development. It also makes diagnosis more ac-
curate and genetics counseling more informed.
We identiﬁed a family with XLMR with ﬁve affected
males in four sibships during a population survey for com-
mon hereditary diseases conducted in Zoucheng, Shan-
dong Province, China, in 1990. Because of the presence
of MR, short stature, and some other physical features
that were suggestive of Smith-Fineman-Myers syndrome
(SFMS), this family was initially reported as having pu-
tative SFMS.4 The causative gene was mapped by linkage
analysis to an interval of 20 Mb between DXS8064 and
DXS8050 on Xq25.5
The initially reported SFMS—together with Carpenter-
Waziri syndrome, Chudley-Lowry syndrome, Juberg-Mar-
sidi syndrome, and Holmes-Gang syndrome—was found
to be caused by mutations in XH2 (also called ATRX and
XNP)3,6 (MIM *300032), a gene that is located at Xq13 and
encodes X-linked helicase 2. These syndromes are now
collectively called “XLMR-hypotonic facies syndrome”
(MIM #309580).3
Employing two polymorphic markers within the XH2
gene, we excluded linkage of the XH2 gene to the disease
in the Zoucheng family with XLMR.7 This ﬁnding, to-
gether with the mapping of the causative gene to Xq25
instead of Xq13, suggests that cases in this family with
XLMR probably represent a syndrome different from
SFMS. Therefore, we revisited the family and reexamined
the patients in 2005. An updated pedigree is shown in
ﬁgure 1. In addition to the ﬁve patients reported else-
where,4 individual IV-11, aged 8 years, was identiﬁed as a
new patient. All adult patients showed mild to moderate
MR and led their daily lives under the care and supervi-
sion of their parents and other relatives. None of the
adult patients were able to speak a single word during their
lifetimes. Deviating from other patients, IV-11 showed
only mild MR and was able to speak several short sen-
tences. No remarkable facial features were noticed. In par-
ticular, the small palpebral ﬁssures, ﬂat nasal bridge, mi-
crognathia, and hypertelorism that are characteristic of
SFMS were not obvious. However, several other physical
features were distinct, including short stature, brachydac-
tyly, large tongue (macroglossia), and a unique gait of
walking with the toes pointing inward. Neuroimaging by
magnetic resonance imaging and computed axial tomog-
raphy scanning revealed no structural abnormalities. In-
terestingly, peripheral blood tests revealed that monocyte
counts, ranging from 0.8#109 to 1.4#109 per liter in four
patients tested, and their percentages, ranging from10.9%
to 17.9% in total white blood cells (WBC), were remark-
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Figure 1. Updated pedigree of a family with XLMR. V-1 was aged 1 year at the time of examination and was found to carry the
mutation. IV-4 was proband (arrow). Blackened symbols represent affected individuals, and symbols with dots represent carriers.
Table 1. A Summary of Phenotypes Observed in Patients of a Family with XLMR
Measure III-13 III-16 IV-2 IV-4 IV-11 IV-12
Age (years) 39 31 30 26 8 18
MR severity Moderate Moderate Moderate Moderate to mild Mild Moderate
Height (cm) and percentile 152, !3rd 159, !10th 140, !1st 160, !10th 124, !50th 158, !10th
OHCa (cm) and percentile 53, !5th 55, !50th 52, !5th 55, !50th 53, !5th 54, !50th
Restlessness      
Absence of speech      
Macroglossia      NE
Brachydactyly      NE
Abduction of small ﬁngers   NE   NE
Gait with toes facing inward      
Monocyte count (109/liter)b 1 1.4 NE 1.3 .8 NE
Monocyte percentagec 17.9 14.3 NE 17.4 10.9 NE
NOTE.—NE p not examined.
a OHC p occipitofrontal head circumference.
b Normal range is 0.3–0.8.
c Normal range is 4%–10%.
ably increased, whereas the total WBC counts were in the
normal range. An updated summary of phenotypes of
patients is listed in table 1. No abnormal phenotypes
were noted in obligate carriers. Considering the exclusion
of XH2 as the causative gene and the presence of some
unique clinical features, we now propose that the disease
in this family represents a novel syndrome.
When additional polymorphic markers became avail-
able, the candidate interval was narrowed to a region of
10.26 Mb between XSTR3 and XSTR4.8 More than 60
genes are located in this region (UCSC Genome Browser).
The search for the disease gene was performed by sequenc-
ing the genes that had been previously associated with
MR or that were expressed in brain within the candidate
interval (ﬁg. 2A). After excluding the ﬁrst 13 genes, we
found a nonsense mutation in the 14th gene tested,
CUL4B (cullin 4B transcript [GenBank accession number
NM_003588]). CUL4B is broadly expressed in most hu-
man tissues and is highly expressed in brain, testis, pros-
tate, colon, and leukocytes, as determined by northern
blot analysis.9 This observation was conﬁrmed by semi-
quantitative RT-PCR (data not shown). CUL4B consists of
22 exons and encodes 913 aa. With the use of intronic
primers (table 2), all exons of the CUL4B gene were am-
pliﬁed and sequenced for two patients of the family. A
base substitution at 1564 in exon 9, c.1564CrT, converted
a codon for arginine (CGA) to a termination codon (TGA),
p.R388X (ﬁg. 2B and 2C). By screening this mutation in
family members, by direct sequencing of exon 9, we found
that this mutation cosegregated with the disease pheno-
type in the family. We also detected the mutation in a boy
aged 1 year, V-1 (ﬁg. 1), and his mother, IV-6, which sug-
gests that this boy is affected and that his mother is a
carrier. The boy, now aged 2 years, appeared to be delayed
in mental development and could not speak or walk. To
conﬁrm the 1564CrT mutation in the family and to de-
tect it in controls, a modiﬁed primer was used to create a
restriction endonuclease (BclI) site to distinguish 1564C
and 1564T alleles. With the use of PCR-RFLP assay, the
sequencing results of all family members were conﬁrmed
(ﬁg. 2D and table 3), and no 1564T allele was detected
among 312 X chromosomes from 264 unrelated, unaf-
fected Chinese controls (216 males and 48 females) (table
3). Thus, it is unlikely that this mutation represents a
polymorphism.
mRNAs that contain premature termination codons
are usually eliminated by a process called “nonsense-me-
diated decay” (NMD).10 To determine whether NMD also
occurs in individuals carrying the 1564CrT mutation, we
measured the mRNA levels of CUL4B in peripheral leu-
kocytes of patients, carriers, and controls. As shown in
table 4, only ∼30% of the mRNA, a 70% reduction, was
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Figure 2. Mutation in CUL4B that causes XLMR. A, Minimal candidate region of 10.26 Mb between XSTR3 and XSTR4. The candidate
genes screened are shown at the bottom. The location of CUL4B is highlighted. B, Partial sequence chromatograms of exon 9 of CUL4B
in a patient and a healthy male from the family. The normal and altered nucleotides at 1564 are labeled with an asterisk (*). C, Genomic
structure of CUL4B and schematic representation of CUL4B protein. The position of the introduced stop codon is indicated by a red
arrow. The position of serine-rich and cullin domains are indicated. D, Conﬁrmation of the c.1564CrT mutation by PCR-RFLP assay. All
patients and carriers exhibited the 172-bp fragment representing the 1564T allele. Part of exon 9 of CUL4B was ampliﬁed from genomic
DNA and was digested with BclI, to distinguish between the 1564C allele (absence of BclI site) and the 1564T allele (presence of BclI
site). Sizes of the resulting restriction fragments are indicated. The primers used in this experiment were 5′-CCAATCATCATGCTTCTCAACT-
3′ (forward) and 5′-CGGTTAGTTTCTTCCAATGATC-3′ (reverse).
retained in the patients when compared with the con-
trols, suggesting that the mRNA was readily eliminated
in those patients, possibly via the NMD mechanism. To
check whether the reduced mRNA level was due to an
altered splicing pattern, we performed RT-PCR, with dif-
ferent primer sets ﬂanking the mutation site, and se-
quenced the PCR products. No altered splicing sites were
detected in the mRNA extracted from peripheral leuko-
cytes of patients (data not shown). Thus, most likely, the
CUL4B mRNA in patients was being degraded via NMD.
The reduced CUL4B mRNA level in patients substantiates
the above notion that 1564CrT is a mutation with func-
tional consequence, instead of a polymorphism.
Interestingly, the CUL4B mRNA levels in carriers were
as high as those in unaffected individuals (table 4). This
is in contrast to a 35% reduction expected in carriers if X
chromosomes were randomly inactivated and cells ex-
pressing either the 1564C allele or the 1564T allele had
equal proliferation capacity. We speculated that themain-
tenance of a high CUL4B mRNA level in carriers was prob-
ably achieved by a selection against cells expressing the
1564T allele, the allele associated with NMD. To test this
hypothesis, we evaluated the X-chromosome inactivation
pattern in carriers and unaffected females, by character-
izing the methylation status of a HpaII site near the highly
polymorphic CAG repeats in the androgen receptor gene
(AR [MIM *313700]).11 The CAG polymorphism distin-
guishes between the maternal and paternal alleles. We
found that X-chromosome inactivation was extremely
skewed in all the informative carriers tested (ﬁg. 3A). In
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Table 2. Primers Used for PCR Ampliﬁcation of CUL4B Exons
Exon
Primer (5′r3′)
Product
Size
(bp)
Annealing
Temperature
(C)Forward Reverse
1 GGGAATAACGAAACCTAGCA CAGACTCACCCTTACCCAAG 801 48
2 CATTCTCCTGCCTAAGCCTCCT CCTGCCAAATCAGCTTGAAATG 542 51
3 CCCTCCACCTCATTGATTAT CTTTCCTTCTCGTCCTCTGT 829 48
4 TTAGAAGGGAACCAAAAGTC GAGAAAAACCTCACCTTCAA 464 48
5 GGCTGAAAAGTCAAAATGTG CAGCCCAAGTAGGATTTTCT 580 51
6 AAATGTCACCTGTACCCCAAT TGCCCTATCAGATTTCCACTT 560 51
7 ACTTTAGTCCCCTCGGCTAAC AATTATATGAGCGTCCCCTTG 598 48
8 GAGATGTGCTTCCTTCAAAC GCAAAATGAGTTTCCTGTGT 474 51
9/10 CCCCTAATAATCGAATCCTT TGAAGGAAGCACATCTCATA 849 48
11 CTTGGGATTAGAAGTGCTTG TTGCCTGTCAGTTCCTTTAT 751 48
12 AGCTACCATTCTCAGGTTGA CAGAAAGATGGTTGGGTTTA 766 51
13 TAGTGTCCAACGTACTGTCTTT TGTCCTCATTTCACTATCAGC 689 48
14 CCCCCAATGAATTAAACAC TTGATCTTCCTGACTTTGGA 393 48
15/16 CCTCAGTTGCCATGAATTAC GGCACAAAAATGGATCTCTA 933 48
17 AGCAGTTGGTATTTGGTGTT TGATCCTTGTATGCCTTTGT 595 48
18 GGAAAGACCACACACCTAAAA ATGTTCAGAGAGAGCAAAAGG 839 48
19 CCTGAGCCATGATTGTACC GATTTCTTGCTGCTTGTGAT 600 51
20 TACAACCACTCTCCCAAACA CCATTGGCTAGAACAAAGAA 498 48
21 AGGGTTTGGCTATCTACCTC AGGATTTTTCTCTGTCAGCA 920 51
22 CAAGTCAAGGGTGGTTTTTC GCCGAAACTGTTGTCTTTTT 653 51
Table 3. 1564CrT Mutation in Patients, Carriers,
and Controls
Group
No. of
Subjects
Nucleotide at
1564a
Pedigree with XLMR:
Patients 7 T
Carriers 6 T/C
Other members 9 C
Controls:
Males 216 C
Females 48 C
NOTE.—Mutation was detected by DNA sequencing (in family
members) and PCR-RFLP assay (in both family members and
controls).
a In GenBank accession number NM_003588, the nucleotide
at 1564 is C.
addition, only the wild-type allele was detected in leu-
kocyte cDNA from those carriers (ﬁg. 3B), indicating that
the mutant allele is completely silenced. This ﬁnding sug-
gests that leukocytes lacking CUL4B are strongly selected
against in vivo. Therefore, CUL4B probably plays a critical
role in normal hematopoiesis. The elevation in themono-
cyte counts may represent one consequence of CUL4B
deﬁciency.
CUL4B belongs to a family of proteins that are charac-
terized by the presence of a highly conserved globular C-
terminal domain and a variable N-terminal helical do-
main.12 Each member of the cullin family can function as
a scaffold in organizing a cullin-RING (really interesting
new gene) ubiquitin ligase complex that recruits and ubi-
quitylates proteins for proteosomal degradation. The C-
terminal domain, together with a RING protein, forms a
catalytic core that covalently attaches ubiquitin to the tar-
geted protein. The N-terminal domain, together with pro-
teins that function as adaptors and receptors, recognizes
and recruits protein substrates. The cullin family consists
of at least seven members in mammals.12 Although Cul4
presents as a single gene in Schizosaccharomyces pombe,
Caenorhabditis elegans, and Drosophila melanogaster, it has
two closely related paralogs, CUL4A and CUL4B, in mam-
mals. A recent study of human DDB1-CUL4A-ROC1 ma-
chinery conﬁrmed that CUL4A adopts a structure similar
to those of other cullins. As an adaptor, DDB1 binds cullin
scaffold through one b-propeller domain and uses a sep-
arate double-b-propeller fold for substrate presentation.13
WD40-repeat proteins can bind the double-b-propeller
fold and serve as a substrate-recruiting module of E3. The
C-terminus of CUL4A, like those of other cullins, forms a
catalytic core. Because of the high degree of homology
betweenCUL4A andCUL4B, it can be assumed thatCUL4B
would adopt a similar structure. As a consequence of the
1564CrT mutation, the truncated peptide would retain
only less than half of the whole protein length at the N-
terminus, leaving the C-terminal domain completely abol-
ished (ﬁg. 2C). Since the C-terminus is required for the
formation of catalytic core, the truncated peptide, if it is
to be synthesized, will have no function. As a matter of
fact, the mRNA level of the mutant CUL4B allele was
greatly reduced in the patients (table 4), which would re-
sult in a very limited production, if any, of the truncated
peptides. In addition, no transcripts due to alternative
splicing were detected (data not shown). In light of these
observations, we propose that the 1564CrTmutation rep-
resents a null mutation.
Our study linked a mutation in CUL4B to a human ge-
netic disorder. Patients lacking CUL4B exhibit structural
or functional abnormalities in multiple systems, notably
in CNS, skeleton, and hematopoiesis. This indicates that
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Figure 3. X-chromosome inactivation that was extremely skewed
in leukocytes of the carriers with the CUL4B mutation. A, Meth-
ylation status of an HpaII site near the CAG repeat of AR was
analyzed. Up undigested; D p digested with HpaII. Methylated
DNA on the inactive X chromosome is resistant to HpaII digestion
and thus can be PCR ampliﬁed with primers ﬂanking the restriction
site. DNA on the active X chromosome, as in patient III-16, is
cleavable by HpaII and gives no PCR products. X-chromosome in-
activation pattern was measured by densitometry as the ratio be-
tween the PCR products from two X chromosomes and was scored
as “random” (ratios 50:50–80:20) or “skewed” (ratios 180:20–
95:5). When only one band was visible, the pattern was scored
as “extremely skewed” (ratio 195:5). Random X inactivation was
observed in unaffected females III-6 (ratio 51:49), III-12 (ratio
52:48), and III-15 (59:41). X inactivation was extremely skewed
toward one chromosome in CUL4B carriers III-2, III-4, III-8, and
III-10, in which only one allele was visible. B, Chromatograms of
the partial sequences from genomic DNA (gDNA) and leukocyte
cDNA in the carriers. Although heterozygous status was observed
in genomic DNA from the carriers (left panel), only the wild-type
allele was detected in their leukocyte cDNA (right panel). The
normal and altered nucleotides at 1564 are labeled with an asterisk
(*).
Table 4. Reduced CUL4B mRNA Levels in Patients, but Not in Carriers, with the
1564CrT Mutation
Group
No. of
Subjects
Average DCt
(CUL4B18S
rRNA)
DCtDCt of
Unaffected
Females
CUL4B mRNA
Ratioa
Patients 5 12.539  .315 1.732  .315 .303
Carriers 4 10.680  .397 .137  .397 1.099
Unaffected females 3 10.816  .572 .000  .572 1.000
Unaffected males 3 10.669  .326 .147  .326 1.107
NOTE.—Total RNA, extracted from peripheral blood cells, was reverse transcribed into cDNA. Real-time
PCR was performed using an ABI PRISM 7500 Sequence Detection System (Applied Biosystems). 18S rRNA
was used as endogenous control. All reactions were run in triplicates. TaqMan probe and primer oligonu-
cleotide sequences are as follows: CUL4B forward primer 5′-TGCTGCTCAGGAGGTCAGATC-3′, reverse primer 5′-
TGGAATCAAAGTCTTCTCTCTCGTT-3′, probe 5′-FAM-TAATACCAGCACCACTCCGCCCACCT-TAMRA-3′; 18S rRNA forward
primer 5′-CGGCTACCACATCCAAGGAA-3′, reverse primer 5′-GCTGGAATTACCGCGGCT-3′, probe 5′-FAM-TGCTGGCACC-
AGACTTGCCCTC-TAMRA-3′. Results were obtained as threshold cycle (Ct) values  SD, which are inversely
proportional to the starting template copy number.
a mRNA ratio of each group to unaffected females.
CUL4B plays a critical role in many aspects of human de-
velopment. Indeed, CUL4B was shown to be expressed in
several human tissues examined.9
Unlike the presence in mammals of two closely related
paralogs, CUL4A and CUL4B, only one gene, Cul4, is pre-
sent in lower organisms. Also, CUL4A and CUL4B were
recently identiﬁed in the same CUL4-DDB1-ROC1 com-
plex that ubiquitylates histones H3 and H4.14 Such ﬁnd-
ings would suggest that CUL4A and CUL4B may have
overlapping functions and compensate for each other.
However, in contrast to the survival of patients with the
CUL4Bmutation into adulthood, knockoutmice forCul4a
die in the embryonic stage,15 indicating that Cul4b is in-
capable of compensating for the lack of Cul4a in the
mouse. The tissue-speciﬁc expression pattern also differs
between CUL4A and CUL4B.9 More importantly, CUL4B
has a much longer N-terminus than CUL4A, which may
enable them each to bind unique adaptors and receptors
in protein recognition and recruitment. A human genetic
disorder caused by mutation in CUL4A has not been re-
ported. A Cul4b-knockout mouse model, which is not yet
available, will deﬁnitely help to achieve more insight into
the functional difference between CUL4A and CUL4B dur-
ing mammalian development and will answer the ques-
tion of whether the phenotypes exhibited by the patients
are species speciﬁc.
Protein ubiquitination regulates the functions of a
broad spectrum of protein substrates in diverse cellular
pathways.16 Many human genetic disorders have been
found to be caused by errors in ubiquitination and pro-
teasomal degradation.17 For example, lack of expression
of UBE3A, a gene that encodes an E3 ubiquitin-protein
ligase, causes Angelman syndrome, which is characterized
by MR, ataxia, absence of speech, and other features.18
Opitz syndrome, which is associated with midline abnor-
malities—such as cleft lip, laryngeal cleft, heart defects,
and hypospadias—and with MR, is caused by an impair-
ment of the E3 ubiquitin ligase activity of the MID1
protein.19,20 Recently, UBE2A, a gene encoding ubiquitin-
conjugating enzyme E2, has also been identiﬁed to be the
cause of a type of syndromic XLMR.21 These ﬁndings sug-
gest that ubiquitylation is critical in cognition as well as
other aspects of human development.
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